Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Sun Pharmaceutical Industries

Sun Pharmaceutical Industries

BSE: 524715|NSE: SUNPHARMA|ISIN: INE044A01036|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 27, 15:59
573.10
-5.35 (-0.92%)
VOLUME 259,476
LIVE
NSE
Jul 27, 15:58
572.10
-7.4 (-1.28%)
VOLUME 5,119,697
News on Sun Pharmaceutical Industries
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Sun Pharma survives tax evasion charge on IPR transfer to foreign arm 

3.37 pm | 27 Jul 2017 |  Source: CNBC-TV18

CNBC-TV18 learns that Sun Pharma survives 'tax evasion' charge on intellectual property rights (IPR) transfer to foreign arm....

Sun Pharma's June quarter results on August 11, 2017

1.11 pm | 26 Jul 2017 |  Source: Moneycontrol.com

This is to inform you that a meeting of the Board of Directors of the Company will be held on Friday, August 11, 2017 to consider and take on record t...

Sun Pharma Q1 PAT may dip 24.69% YoY to Rs 1713.2 cr: KR Choksey

6.42 pm | 18 Jul 2017 |  Source: Moneycontrol.com

Net Sales are expected to decrease by 2.39 percent Q-o-Q (down 16.79 percent Y-o-Y) to Rs 6662 crore, according to KR Choksey. Sun Pharma to report ne...

Hold Sun Pharma, says Sharmila Joshi 

3.12 pm | 18 Jul 2017 |  Source: CNBC-TV18

According to Sharmila Joshi of sharmilajoshi.com, one may hold Sun Pharma....

Remain invested in Sun Pharma: Rajat Bose 

3.10 pm | 18 Jul 2017 |  Source: CNBC-TV18

Rajat Bose of rajatkbose.com is of the view that one may remain invested in Sun Pharmaceutical Industries....

Q1 Earnings preview: Pharma to see muted growth due to pricing pressure in US, GST disruption in domestic market

10.09 pm | 13 Jul 2017 |  Source: Moneycontrol.com

Analysts predict the June quarter to be tough with revenues in the best case scenario moderating to low single digit growth and in the worst case decl...

Indian pharma market grew at 7.5% in June amidst GST rollout concerns

7.01 pm | 12 Jul 2017 |  Source: Moneycontrol.com

The growth was led by rebound of anti-infective medicines and continued momentum of chronic segment. Analysts feared much worse growth in June due to...

Sun Pharma, Zee Entertainment looks good: Prakash Gaba 

1.27 pm | 10 Jul 2017 |  Source: CNBC-TV18

Prakash Gaba of prakashgaba.com is of the view that Sun Pharma looks good for target of Rs 580 and Zee Entertainment for target of Rs 520....

Buy Sun Pharmaceutical Industries, Tata Consultancy Services: Sudarshan Sukhani 

12.31 pm | 10 Jul 2017 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends buying Sun Pharmaceutical Industries and Tata Consultancy Services....

Time to look at contrarian calls; like Sun Pharma Bajaj Auto, PNB: Motilal Oswal Sec 

11.27 am | 04 Jul 2017 |  Source: CNBC-TV18

Gautam Duggad, Head of Research, Institutional Equities at Motilal Oswal Securities in an interview with CNBC-TV18 talked about the rationale behind t...

Sun Pharma inks $55.5-mn deal for anti-psoriasis drug

11.15 am | 04 Jul 2017 |  Source: PTI

"The agreement was entered into by Sun Pharma's wholly- owned subsidiary and Samsung BioLogics...Sun Pharma has appointed Samsung BioLogics to man...

Sun Pharma to outsource manufacturing of its psoriasis drug candidate to Samsung BioLogics

9.35 am | 04 Jul 2017 |  Source: Moneycontrol.com

Sun Pharma, India's largest drug maker on Tuesday, said it has entered into a strategic agreement with Samsung BioLogics to manufacture the former...

Sun Pharma, Samsung BioLogics announce strategic manufacturing tie-up for Tildrakizumab

8.15 am | 04 Jul 2017 |  Source: Moneycontrol.com

Sun Pharma and Samsung BioLogics announced a strategic long-term manufacturing agreement for Tildrakizumab....

Here's 360 degree view on Sun Pharmaceutical & CDSL 

2.58 pm | 30 Jun 2017 |  Source: CNBC-TV18

Watch CNBC-TV18's analysts giving a 360 degree round up on specific stocks and sectors. The stocks in focus today are Sun Pharmaceutical and CDSL....

Buy Sun Pharma, Lupin, Asian Paints, Yes Bank, Balrampur Chini, BASF: Ashwani Gujral 

2.28 pm | 30 Jun 2017 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com recommends buying Sun Pharma, Lupin, Asian Paints, Yes Bank, Balrampur Chini and BASF....

Aurobindo, Cipla, Biocon top picks; see FDA plan to be double edged sword: Citi

12.32 pm | 29 Jun 2017 |  Source: Moneycontrol.com

In the last nine months to one year time, the pharma stock prices were plummeted by 20-35 percent....

Sun Pharma & NIV sign agreement to fight Zika, Chikungunya and Dengue

8.20 am | 27 Jun 2017 |  Source: Moneycontrol.com

Sun Pharma and The National Institute of Virology (NIV) have signed an agreement for testing phytopharmaceutical, biologic and chemical entities devel...

Pharma wrap: USFDA promises faster approvals, Aadhaar must for TB treatment

4.15 pm | 24 Jun 2017 |  Source: Moneycontrol.com

After three weeks of decent show this week most pharma stocks ended red. The week highlights include government making Aadhaar mandatory for treatment...

Buy Sun Pharma; target of Rs 650: Motilal Oswal

3.49 pm | 15 Jun 2017 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 650 in its research report dated June 14, 201...

Hold Sun Pharmaceuticals; target of Rs 549: ICICI Direct

5.19 pm | 29 May 2017 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Sun Pharmaceuticals with a target price of Rs 549 in its research report dated May 29, 2017....

1 2 3 4 5 6
Quick Links for Sun Pharmaceutical Industries
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.